Discover 4,546 paid clinical trials in Texas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
VenoStent
Location:
Code:
NCT06001827
Conditions
Chronic Kidney Diseases
End Stage Renal Disease
Arteriovenous Fistula
Hemodialysis Access Failure
ESRD
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SelfWrap Bioabsorbable Perivascular Wrap
Untreated AVF Control
Sponsor:
Brooke Army Medical Center
Location:
Code:
NCT02482727
Conditions
Distal Radius Fracture
Rehabilitation
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
occlusion training with tourniquet (DELFI PTS ii portable tourniquet system)
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT04678427
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 6 - 29
Healthy Volunteers: Not accepted
Interventions
6 Minute Walk Functional Test
Behavioral Intervention
Survey Administration
Timed Get Up and Go Test
Sponsor:
The University of Texas Medical Branch, Galveston
Location:
Code:
NCT05934773
Conditions
Acquired Brain Injury
Stroke
Traumatic Brain Injury
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
KineAssist robotic treadmill
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT01515527
Conditions
Leukemia
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Interventions
Cladribine
Cytarabine
Decitabine
Sponsor:
Jacobio Pharmaceuticals Co., Ltd.
Location:
Code:
NCT04720976
Conditions
Solid Tumor
NSCLC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
JAB-3312
Binimetinib
Pembrolizumab
Sotorasib
Osimertinib
Sponsor:
AbbVie
Location:
Code:
NCT04064827
Conditions
Chronic Kidney Disease (CKD)
Secondary Hyperparathyroidism (SHPT)
Eligibility Criteria
Sex: All
Age: 0 - 9
Healthy Volunteers: Not accepted
Interventions
Paricalcitol
Sponsor:
The University of Texas at Dallas
Location:
Code:
NCT03932773
Conditions
Post Traumatic Stress Disorder
Eligibility Criteria
Sex: All
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Active rTMS
Sham rTMS
Cognitive Processing Therapy
Sponsor:
Cullinan Therapeutics Inc.
Location:
Code:
NCT05117476
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CLN-619
Pembrolizumab
Sponsor:
Weill Medical College of Cornell University
Location:
Code:
NCT06811376
Conditions
Advanced Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Spiritual Care Intervention #1
Spiritual Care Intervention #2
With a broad healthcare network and leading medical research centers, Texas is a key location for a wide range of clinical trials. Major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and Texas Heart Institute are at the forefront of these studies.
Texas offers unique advantages for those participating in clinical trials. The state's diverse population provides a broad range of participants, which enhances the reliability and relevance of research findings. Texas is also known for its innovative research environment, with a strong focus on medical advancements and cutting-edge studies.
By choosing to participate in a clinical trial in Texas, you contribute to important medical research while benefiting from a well-established and supportive clinical research system.
Clinical trials in Texas cover a broad range of health conditions, offering participants the opportunity to contribute to medical advancements while accessing innovative treatments.
Texas is home to world-leading cancer research institutions, making it a key location for oncology trials. These trials offer access to innovative treatments, such as new drugs, immunotherapies, and advanced radiation techniques that are not yet widely available.
As a major center for oncology research, Texas conducts clinical trials that cover a broad spectrum of cancers, including breast cancer, lung cancer, leukemia, colorectal cancer, prostate cancer, and liver cancer. These trials emphasize the development of targeted therapies, advancements in immunotherapy, and the exploration of combination treatments to improve the effectiveness of current cancer treatments.
Texas plays a major role in researching treatments for neurological conditions, particularly in areas such as stroke prevention, Alzheimer’s disease, Parkinson's disease, epilepsy, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS).
Clinical trials in these areas focus on developing innovative therapies, such as new drugs, brain stimulation devices, and gene therapies, with the goal of slowing disease progression and improving early intervention strategies.
Heart disease is a leading cause of death across the United States, making cardiovascular clinical trials a top priority in Texas. These studies investigate conditions such as heart failure, coronary artery disease, hypertension, and atrial fibrillation.
Research centers are dedicated to developing new treatments and improving preventative measures to combat this widespread health issue, with the goal of reducing its impact on millions of people. Innovations being tested include next-generation heart devices, new cholesterol-lowering medications, and minimally invasive cardiovascular procedures, all aimed at reducing the impact of these conditions on the population.
Chronic conditions such as diabetes and obesity are significant health challenges across the United States. Clinical trials in Texas are essential for advancing the management and treatment of these widespread issues.
These trials play an important role in evaluating new diabetes medications, exploring weight-loss therapies, and developing advanced treatments for respiratory and kidney diseases. By focusing on these areas, Texas contributes to improving care and outcomes for long-term health conditions like Type 1 and Type 2 diabetes, asthma, and chronic obstructive pulmonary disease (COPD).
Infectious diseases remain a critical area of study in Texas, especially given the state’s role in COVID-19 vaccine research and other viral disease treatments. Several prominent research institutions and hospitals in Texas, such as The University of Texas Medical Branch (UTMB) in Galveston, Baylor College of Medicine in Houston, and the Texas Biomedical Research Institute in San Antonio, were involved in key phases of vaccine trials.
In addition to its significant role in the initial development of COVID-19 vaccines, clinical trials in the state are also focusing on several key areas such as evaluating the efficacy of antiviral drugs, and exploring new strategies for HIV/AIDS prevention. Research efforts also encompass other important areas such hepatitis C, tuberculosis, and influenza, aiming to improve treatments and prevention methods for these prevalent infectious diseases.
With rising awareness of mental health challenges, Texas is a growing center for clinical research aimed at improving treatment options for psychiatric and behavioral disorders. Clinical trials explore both pharmaceutical solutions and therapeutic interventions.
Clinical trials address conditions such as depression, anxiety disorders, PTSD, schizophrenia, and bipolar disorder. These studies focus on testing novel antidepressants, anxiety-reducing therapies, and psychotherapies, aiming to provide better treatment options for individuals facing mental health challenges.
Texas also supports clinical trials for rare diseases, offering new hope to patients with conditions that have limited treatment options. These studies often focus on genetic conditions and explore groundbreaking treatments like gene therapy.
Clinical trials cover conditions such as cystic fibrosis, Duchenne muscular dystrophy, rare cancers, and other inherited disorders. Research efforts focus on gene editing, enzyme replacement therapies, and drug development, pushing forward groundbreaking treatments for these often overlooked diseases.
In Texas, clinical trials are governed by strict local regulations and guidelines to ensure the highest standards of safety and ethics. The Texas Department of State Health Services oversees clinical trials to ensure they adhere to state and federal standards. Researchers must obtain Institutional Review Board (IRB) approval, which involves a thorough review of the study’s design, risks, and benefits to protect participant welfare.
Informed consent is a crucial element for participants, ensuring they receive detailed information about the trial's purpose, procedures, potential risks, and benefits before agreeing to take part. Additionally, stringent privacy regulations are in place to protect the confidentiality of participants' medical information, upholding high standards of data security throughout the research process.
Participating in clinical trials offers numerous benefits, including access to cutting-edge treatments and therapies that are not yet available to the general public. Participants often receive close monitoring and care from top medical professionals, ensuring a high level of attention and support throughout the study.
Additionally, involvement in clinical trials contributes to important medical research that can lead to advancements in treatment and care for future patients. By participating, individuals not only gain early access to potentially groundbreaking interventions but also play an important role in advancing scientific knowledge and improving healthcare outcomes for others.
Worried about the risks of participating in a clinical trial? Read our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: